Howard E. Boudreau, Ph.D.

Staff Scientist

Contact: For contact information, search the NIH Enterprise Directory.

Provides direct clinical care to patients at NIH Clinical Center

Education:

Ph.D., 2006, Georgetown University

Biography

Howard Boudreau obtained his Ph.D. in Biochemistry and Molecular & Cellular Biology from Georgetown University in 2006. His graduate work focused on identifying and characterizing novel effector targets of the Raf-1/ERK signaling pathway in metastatic breast cancer. As a post-doctoral fellow at NIH/NIAID, he focused on roles of NADPH oxidase (NOX) enzymes in TGF-beta-mediated inflammation and wound healing. In 2014, he joined the Molecular Defenses Section (MDS) as a Staff Scientist in the Laboratory of Clinical Immunology and Microbiology (LCIM) and studies how tumor-associated mutant p53 proteins and NOX4 contribute to cancer cell migration and inflammation.